Heterozygosity for the common LCHAD mutation (1528G>C) is not a major cause of HELLP syndrome and the prevalence of the mutation in the dutch population is low

Pediatric Research

Volumn 48, Issue 2, 2000, Pages 151-154

  Den Boer, Margarethe E J ^a   Ijlst, Lodewijk ^a   Wijburg, Frits A ^a   Oostheim, Wendy ^a   Van Werkhoven, Michiel A ^a   Van Pampus, Marielle G ^a   Heymans, Hugo S A ^a   Wanders, Ronald J A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; M PROTEIN;

ALPHA CHAIN; ARTICLE; ENZYME ACTIVITY; ENZYME DEFICIENCY; FATTY ACID OXIDATION; FEMALE; GENE MUTATION; HELLP SYNDROME; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYMPTOMATOLOGY;

EID: 0033916399     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200008000-00006     Document Type: Article

References (27)

1. Mitochondrial fatty acid oxidation disorders
2. Long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency with the G1528C mutation: Clinical presentation of 13 patients
3. The Clinical spectrum of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
4. Peripheral sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxyacyl CoA dehydrogenase deficiency
5. Progressive neuropathy and recurrent myoglobinuria in a Child with long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency
6. 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: Protective effect of medium-chain triglyceride treatment
7. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders
8. Molecular basis of hepatic carnitine palmitoyltransferase I deficiency
9. Human trifunctional protein deficiency: A new disorder of mitochondrial fatty acid β-oxidation
10. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Identification of a new inborn error of mitochondrial fatty acid β-oxidation
11. Structures of the human cDNA and gene encoding the 78 kD gastrin-binding protein and of a related pseudogene
12. Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
13. Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Identification of the major disease-causing mutation in the α-subunit of the mitochondrial trifunctional protein
14. The molecular basis of pediatric long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy
15. Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
16. Pregnancy and fetal long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
17. The HELLP syndrome
18. Acute fatty liver of pregnancy: A clinicopathologic study of 35 cases
19. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
20. Recurrent acute fatty liver of pregnancy associated with fatty-acid oxidation defect in the offspring
21. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material
22. Population screening for carrier status: Effects of test limitations on precision of carrier prevalence rates
23. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Much ado about nothing?
24. Medium-chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected children
25. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: The prevalent mutation G985 (K304E) is subject to a strong founder effect from northwestern Europe
26. Prevalence of carriers of the most common medium-chain acyl-CoA dehydrogenase (MCAD) deficiency mutation (G985A) in The Netherlands
27. Improved detection of the G1528C mutation in LCHAD deficiency